Despite the known functional relationship between FGF23 and α-klotho, there have been few clinical studies evaluating these biomarkers simultaneously in patients with dialysis-dependent-CKD, as well as studies concerning the effects of drugs such as iron-containing products. The gene discussed is KL; the disease is chronic kidney disease.